The government plans to roll out a nationwide free medicine scheme by November, which will offer quality essential drugs to all the patients in state-run hospitals and treatment centres, a senior health ministry official said. LC Goyal, additional secretary in the ministry of health and family welfare, said the scheme would offer 348 essential drugs as well as their combinations to patients. These drugs account for about 28 per cent of...

-The Hindustan Times Bollywood star Aamir Khan had two simple prescriptions for a Parliamentary committee to reduce high health costs for citizens. First, make doctors prescribe generic medicines rather than brands. Second, set up a regulator to ensure big pharmaceutical don’t take over smaller ones and monopolise the medicine market. Khan and his team were invited on Thursday by the Parliamentary Standing Committee on Commerce headed by BJP MP Shanta Kumar, which...

-The Economic Times A growing number of countries are adopting India's intellectual property regulations, which give enough flexibility to local companies to produce generic versions of popular drugs to safeguard public health. Although multinational companies have criticised India for being lax in enforcing intellectual property (IP) laws, countries such as China, Argentina and the Philippines are adopting similar provisions. Last month, China amended its IP laws, allowing local companies to produce low-cost versions...

-The Hindu About 40 networks and civil society groups from 16 districts of Rajasthan on Saturday demanded that the flagship free medicine supply scheme at government hospitals in the State be brought under an independent legislation or included in the Rajasthan Public Services Guarantee Act, 2011, to remove bottlenecks being faced for the past eight months. Activists under the banner of Jan Swasthya Abhiyan praised the scheme for its reach and objectives,...

-The Hindu The World Health Organisation (WHO) has put in place a mechanism to define counterfeit medical products. The set of definitions of sub-standard, spurious, falsely labelled, falsified and counterfeit products will be globally accepted and help to bring about uniformity in identifying such drugs, without interrupting worldwide supplies. The decision to establish a member state mechanism was taken at the World Health Assembly, the WHO's policymaking body, at a meeting held recently. The...